Ligand validation:6MH9

PLM: PALMITIC ACID

PLM is a Ligand Of Interest in 6MH9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MH9_PLM_A_301	53%	51%	0.152	0.913	1.25	0.66	2	-	3	0	100%	1
6MH9_PLM_B_301	41%	51%	0.169	0.882	1.25	0.65	1	-	3	0	100%	1
7SCL_PLM_A_301	83%	51%	0.078	0.937	1	0.89	1	2	0	0	100%	1
5UTO_PLM_B_301	75%	56%	0.118	0.95	0.98	0.74	2	1	0	0	100%	1
6NYU_PLM_B_302	55%	57%	0.17	0.938	0.91	0.75	1	2	4	0	100%	0.32
7SG3_PLM_A_301	6%	72%	0.365	0.795	0.56	0.54	-	-	12	0	100%	1
4TKJ_PLM_A_201	99%	67%	0.056	0.987	0.64	0.62	-	-	0	0	100%	1
5B28_PLM_A_201	99%	74%	0.059	0.986	0.43	0.59	-	-	0	0	100%	1
4BVM_PLM_A_1132	98%	53%	0.062	0.988	0.62	1.17	-	2	1	0	100%	0.46
6S2S_PLM_A_203	98%	44%	0.069	0.988	1.32	0.86	4	-	1	0	100%	0.5
3CUE_PLM_E_194	98%	36%	0.075	0.994	1.12	1.37	1	3	6	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.